An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer

被引：0
|
作者：
H E Lee
J H Kim
Y J Kim
S Y Choi
S-W Kim
E Kang
I Y Chung
I A Kim
E J Kim
Y Choi
H S Ryu
S Y Park
机构：
[1] Seoul National University Hospital,Department of Pathology
[2] Seoul National University College of Medicine,Department of Internal Medicine
[3] Seoul National University College of Medicine,Department of Surgery
[4] Breast Care Center,Department of Radiation Oncology
[5] Seoul National University Bundang Hospital,Department of Pathology
[6] 300 Gumi-dong,Department of Pathology
[7] Bundang-gu,undefined
[8] Seongnam-si,undefined
[9] Gyeonggi 463-707,undefined
[10] Korea,undefined
[11] Seoul National University College of Medicine,undefined
[12] Seoul National University Bundang Hospital,undefined
[13] Seoul National University College of Medicine,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
breast cancer; cancer stem cells; primary systemic therapy; chemoresistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1730 / 1738
页数：8
相关论文
共 50 条
  • [21] Validation of prognostic and predictive value of total tumoral load after primary systemic therapy in breast cancer using OSNA assay
    Laia Bernet-Vegué
    Carolina Cantero-González
    Magdalena Sancho de Salas
    David Parada
    Tiziana Perin
    Zulma Quintero-Niño
    Begoña Vieites Pérez-Quintela
    Douglas Sánchez-Guzmán
    Marina Castelvetere
    David Hardisson Hernaez
    María Dolores Martín-Salvago
    Clinical and Translational Oncology, 2024, 26 : 1220 - 1228
  • [22] TMPRSS3 is a novel poor prognostic factor for breast cancer
    Rui, Xue
    Li, Yanshu
    Jin, Feng
    Li, Feng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5435 - 5442
  • [23] Ketones and lactate increase cancer cell "stemness", driving recurrence, metastasis and poor clinical outcome in breast cancer
    Martinez-Outschoorn, Ubaldo E.
    Prisco, Marco
    Ertel, Adam
    Tsirigos, Aristotelis
    Lin, Zhao
    Pavlides, Stephanos
    Wang, Chengwang
    Flomenberg, Neal
    Knudsen, Erik S.
    Howell, Anthony
    Pestell, Richard G.
    Sotgia, Federica
    Lisanti, Michael P.
    CELL CYCLE, 2011, 10 (08) : 1271 - 1286
  • [24] Selective sentinel lymph node biopsy and primary systemic therapy in breast cancer
    Pinero, Antonio
    Gimenez, Julia
    Vidal-Sicart, Sergi
    Intra, Mattia
    TUMORI JOURNAL, 2010, 96 (01): : 17 - 23
  • [25] Issues in the assessment of the pathologic effect of primary systemic therapy for breast cancer.
    Kuroi K.
    Toi M.
    Tsuda H.
    Kurosumi M.
    Akiyama F.
    Breast Cancer, 2006, 13 (1) : 38 - 48
  • [26] Radiation therapy volumes after primary systemic therapy in breast cancer patients: an international EUBREAST survey
    Gasparri, Maria Luisa
    Kaidar-Person, Orit
    Gentilini, Oreste Davide
    de Boniface, Jana
    Kuehn, Thorsten
    Poortmans, Philip
    RADIATION ONCOLOGY JOURNAL, 2024, 42 (04): : 308 - 318
  • [27] Advances in adjuvant and primary systemic therapy of early breast cancer
    Bischoff, Joachim
    Costa, Serban-Dan
    BREAST CARE, 2006, 1 (02) : 129 - 133
  • [28] Taxanes in primary systemic treatment of breast cancer
    von Minckwitz, G
    ONKOLOGIE, 2003, 26 : 21 - 25
  • [29] Assessment and Localisation of Response to Primary Systemic Therapy in Breast Cancer
    Noble, Frith
    ULTRASOUND, 2009, 17 (02) : 80 - 84
  • [30] Tissue Factor promotes breast cancer stem cell activity in vitro
    Shaker, Hudhaifah
    Harrison, Hannah
    Clarke, Robert
    Landberg, Goran
    Bundred, Nigel J.
    Versteeg, Henri H.
    Kirwan, Cliona C.
    ONCOTARGET, 2017, 8 (16) : 25915 - 25927
12345